» Articles » PMID: 1598575

High-efficiency Expression and Solubilization of Functional T Cell Antigen Receptor Heterodimers

Overview
Journal Science
Specialty Science
Date 1992 May 29
PMID 1598575
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The T cell receptor (TCR) zeta chain was attached to the TCR alpha and beta extracellular domains to induce efficient expression of alpha beta heterodimers that can recognize complexes of antigen with major histocompatibility complex (MHC) molecules. Chimeric constructs expressed in RBL-2H3 cells were efficiently transported to the cell surface uniquely as disulfide-linked heterodimers. Transfectants were activated by specific antigen-MHC complexes, which demonstrated that the expressed alpha beta was functional and that CD3 was not required for antigen-MHC binding. Constructs with thrombin cleavage sites were efficiently cleaved to soluble disulfide-linked heterodimers. Thus, attachment of TCR zeta domains and protease cleavage sites to TCR alpha and beta induces expression of demonstrably functional heterodimers that can be solubilized.

Citing Articles

Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins.

Lunde E, Loset G, Bogen B, Sandlie I BMC Biotechnol. 2010; 10:61.

PMID: 20735812 PMC: 2936418. DOI: 10.1186/1472-6750-10-61.


Cloning and expression of human membrane-bound and soluble engineered T cell receptors for immunotherapy.

Alajez N, Eghtesad S, Finn O J Biomed Biotechnol. 2006; 2006(2):68091.

PMID: 16883054 PMC: 1510948. DOI: 10.1155/JBB/2006/68091.


Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

Alajez N, Schmielau J, Alter M, Cascio M, Finn O Blood. 2005; 105(12):4583-9.

PMID: 15746083 PMC: 1894994. DOI: 10.1182/blood-2004-10-3848.


A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.

Card K, Price-Schiavi S, Liu B, Thomson E, Nieves E, Belmont H Cancer Immunol Immunother. 2003; 53(4):345-57.

PMID: 14610621 PMC: 11034328. DOI: 10.1007/s00262-003-0450-3.


T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors.

Dornmair K, Goebels N, Weltzien H, Wekerle H, Hohlfeld R Am J Pathol. 2003; 163(4):1215-26.

PMID: 14507631 PMC: 1868314. DOI: 10.1016/S0002-9440(10)63481-5.